Russia’s Sputnik V, the world’s first vaccine registered against the coronavirus disease (Covid-19), has been recommended for emergency use by experts in India. Soon, it is likely to get the final nod as the country’s third vaccine — after Bharat Biotech’s Covaxin and Oxford-AstraZeneca’s Covishield — at a time when there is a worrying spike in cases linked to the viral infection.